SELLAS Announces Positive Follow-Up Phase 1/2 Clinical Data for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach